Abstract: To design the frequency selective surface (FSS) with more degrees of freedom (DoFs) and incident angle stability, an improved machine learning-based inverse topological design model is ...
Galapagos is planning to wind down its cell therapy business, completing a whiplash change that saw the biotech go from focusing on the modality to ditching it in six months. Belgium-based Galapagos ...
(10 December 2025 - Oslo, Norway) Reference is made to the stock exchange release by Hexagon Purus ("the "Company") on 18 April 2023 and 25 October 2024, where Hexagon Purus Systems USA LLC, a ...
Ozempic maker Novo Nordisk (NVO) is closing its cell therapy division as part of a major restructuring drive initiated under the company’s new CEO, Mike Doustdar, Bloomberg News reported on Thursday, ...
Novo Nordisk is ending all work in cell therapy, including a Type 1 diabetes program, amid CEO Maziar Mike Doustdar's reorganization. As part of the move, the company is laying off nearly all of the ...
Hexagon shares rose after the Swedish measurement-technology group said it agreed to sell its design and engineering business to Cadence Design Systems for 2.7 billion euros ($3.15 billion). Shares in ...
Cadence Design Systems, Inc. CDNS has signed a definitive agreement to acquire the Design & Engineering (D&E) division of Hexagon AB, including its renowned MSC Software business, an industry pioneer ...
Sept 4 (Reuters) - Cadence Design (CDNS.O), opens new tab said on Thursday it will buy the design and engineering business of Stockholm-based Hexagon AB (HEXAb.ST), opens new tab for 2.7 billion euros ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback